Surface Ophthalmics
Pleasanton, US · Founded 2017 · Delaware corporation
Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.
Founders & leadership
PS
Perry SternberginExecutive
KH
Kamran HosseiniNamed on SEC filing
Board
MB
Mark BaumBoard director
JA
J. Andy CorleyBoard director
ST
Shelley ThunenBoard director
AG
Adrienne GravesBoard director
RL
Richard LindstromBoard director
Reported raises · per SEC filings
Form D private placements$40.1M disclosed across 2 rounds · 2018–2021
▶$25.1MraisedAug 2021 · 444 investors · Other Health CareRule 506(b)
▶$25.1MraisedAug 2021 · 444 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark BaumDirector
- Kamran HosseiniExecutive Officer, Director
- Shelley ThunenDirector
- Adrienne GravesDirector
- Perry SternbergExecutive Officer, Director
- Richard LindstromDirector
- J. Andy CorleyDirector
- Offering amount
- $30.6M
- Amount sold
- $25.1M
- Finders' fees
- $1.5M
- Placement agents
- Newbridge Securities Corporation
- First sale
- May 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$15MraisedMay 2018 · 1 investors · PharmaceuticalsRule 506(b)
▶$15MraisedMay 2018 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard L. LindstromDirector
- Louis DrapeauDirector
- Adrienne GravesDirector
- Kamran HosseiniExecutive Officer, Director
- Mark BaumExecutive Officer, Director
- J. Andrew CorleyDirector
- Offering amount
- $20M
- Amount sold
- $15M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapHilco Vision24 shared keywordsHilco Vision manufactures and distributes lens care products including cleaners, wipes, and protective accessories for eyewear. The company serves optical practices and eyewear retailers with both standard and custom-branded solutions.
Ois21 shared keywordsOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.
Alcon16 shared keywordsAlcon develops eye care products and medical technologies, including the Valeda Photobiomodulation (PBM) system for retina treatment, for eye care professionals such as retina specialists.
Stuarttherapeutics14 shared keywordsStuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.
Zocdoc14 shared keywordsZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
Companies competing with Surface Ophthalmics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Surface Ophthalmics do?
- Surface Ophthalmics is a biopharmaceutical company developing topical eyedrop treatments for dry eye syndrome and post-surgical ocular conditions. The company has evaluated multiple formulations through Phase II clinical trials and is pursuing three proprietary candidates for commercialization.
- How much funding has Surface Ophthalmics raised?
- Surface Ophthalmics has disclosed $40.1M raised across 2 rounds.
- Where is Surface Ophthalmics headquartered?
- Surface Ophthalmics is headquartered in Pleasanton, US.